×
For best experience we recommend to activate Javascript in your browser.
GALNS antibody (AA 168-377)
This anti-GALNS antibody is a Rabbit Polyclonal antibody detecting GALNS in WB, IHC, ICC and IP. Suitable for Mouse.
Quick Overview for GALNS antibody (AA 168-377) (ABIN7623093)
Target
See all GALNS Antibodies
GALNS
(Galactosamine (N-Acetyl)-6-Sulfate Sulfatase (GALNS))
Reactivity
All reactivities for GALNS antibodies
Mouse
Host
All hosts for GALNS antibodies
Rabbit
Clonality
All clonalities for GALNS antibodies
Polyclonal
Conjugate
All conjugates for GALNS antibodies
This GALNS antibody is un-conjugated
Application
All applications for GALNS antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunoprecipitation (IP)
Product Details anti-GALNS Antibody
(hide)
Binding Specificity
All epitopes for GALNS antibodies
AA 168-377
Purpose
N-Acetylgalactosamine-6-Sulfatase (GALNS) Polyclonal Antibody
Sequence
Asp168~Asp377
Characteristics
The N-Acetylgalactosamine-6-Sulfatase (GALNS) Polyclonal Antibody (Species: Mouse) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for GALNS
(hide)
Target
GALNS
(Galactosamine (N-Acetyl)-6-Sulfate Sulfatase (GALNS))
Alternative Name
GALNS
Gene ID
50917
UniProt
Q571E4
Pathways
Glycosaminoglycan Metabolic Process
Recently viewed
(hide)
Chat with us , powered by LiveChat